Clay B. Siegall

2015

In 2015, Clay B. Siegall earned a total compensation of $6.9M as President and CEO at Seattle Genetics, which was about the same as previous year.

Compensation breakdown

Bonus$603
Non-Equity Incentive Plan$1,018,750
Option Awards$2,524,405
Salary$813,457
Stock Awards$2,505,600
Other$8,430
Total$6,871,245

Siegall received $2.5M in option awards, accounting for 37% of the total pay in 2015.

Siegall also received $603 in bonus, $1M in non-equity incentive plan, $813.5K in salary, $2.5M in stock awards and $8.4K in other compensation.

Rankings

In 2015, Clay B. Siegall's compensation ranked 1,008th out of 13,638 executives tracked by ExecPay. In other words, Siegall earned more than 92.6% of executives.

ClassificationRankingPercentile
All
1,008
out of 13,638
93rd
Division
Manufacturing
355
out of 5,187
93rd
Major group
Chemicals And Allied Products
129
out of 1,857
93rd
Industry group
Drugs
98
out of 1,531
94th
Industry
Biological Products, Except Diagnostic Substances
15
out of 260
94th
Source: SEC filing on April 5, 2017.

Siegall's colleagues

We found five more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2015.

2015

Jonathan Drachman

Seattle Genetics

Chief Medical Officer

2015

Eric Dobmeier

Seattle Genetics

Chief Operating Officer

2015

Todd Simpson

Seattle Genetics

Chief Financial Officer

2015

Jean Liu

Seattle Genetics

General Counsel

2015

Vaughn Himes

Seattle Genetics

Chief Technical Officer

News

You may also like